ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
VYX
NCR Voyix Corporation
VYX has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
VYX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Under pressure |
VYX's profitability is currently healthy, but its revenue, cash flow and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
VYX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2x | $1.45 | -85% |
| Forward | 9.5x | $9.96 | — |
| Current | 14x | $9.96 | — |
| Fair | 22x | $15.83 | +59% |
| Expensive | 68x | $49.30 | +395% |
Historical ranges are pointers, not guarantees.
VYX's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
VYX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect VYX's earnings to grow and its profitability to improve, but its revenue to decline.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
VYX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.05 | +45% |
| Q3 2026 | $0.72 | +$1.16 |
| Q2 2026 | $0.41 | -94% |
| Q1 2026 | $0.39 | -94% |
| Q4 2025 | $0.30 | -95% |
| Q3 2025 | -$0.44 | -110% |
| Q2 2025 | $7.13 | +$11.16 |
| Q1 2025 | $6.63 | +$10.02 |
| Q4 2024 | $6.47 | +$9.51 |
VYX has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over VYX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
VYX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $539M | -21% |
| Q2 2026 | $523M | -21% |
| Q1 2026 | $606M | -1.8% |
| Q4 2025 | $720M | +5.6% |
| Q3 2025 | $684M | -3.8% |
| Q2 2025 | $666M | -24% |
| Q1 2025 | $617M | -28% |
| Q4 2024 | $682M | -29% |
VYX's revenue has slid since its 2021 peak: $539M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +5.6 points |
| Q2 2026 | 2.7% | +0.6 points |
| Q1 2026 | -3.1% | +0.1 points |
| Q4 2025 | 2.4% | +2.1 points |
| Q3 2025 | 2.2% | +0.1 points |
| Q2 2025 | 2.1% | +2.6 points |
| Q1 2025 | -3.2% | -3.7 points |
| Q4 2024 | 0.3% | +14 points |
VYX has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
VYX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20M | -300% |
| Q2 2026 | -$24M | +$225M |
| Q1 2026 | $6M | +$56M |
| Q4 2025 | -$86M | +$91M |
| Q3 2025 | $10M | +11% |
| Q2 2025 | -$249M | -608% |
| Q1 2025 | -$50M | -$7M |
| Q4 2024 | -$177M | -$125M |
VYX has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
VYX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +2M shares |
| 1 year | +1.2% | +1.6M shares |
| 3 years | -0.8% | -1.1M shares |
| 5 years | +1.5% | +2M shares |
| Available history | -3.7% | -5.4M shares |
VYX has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8M |
| Q2 2026 | $11M |
| Q1 2026 | $9M |
| Q4 2025 | $5M |
| Q3 2025 | — |
| Q2 2025 | $7M |
| Q1 2025 | $62M |
| Q4 2021 | — |
VYX spent $33M buying back its own shares over the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VYX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.1x | Elevated |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 2.0x | Healthy |
| Q4 2024 | 1.2x | Healthy |
VYX's net debt is about 3.0 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
VYX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.3 | Neutral |
| Stochastic | 69.5 | Neutral |
VYX's weekly RSI is 62 (neutral) and its Stochastic is 70 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
VYX PE vs Technology Sector
| Metric | VYX | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 50% below |
| PE % | 35 | 35 | Same percentile |
VYX is trading at 14x earnings, a 50% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
VYX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.14 | 22% above |
| 20 week MA | $8.18 | 22% above |
| 50 week MA | $8.25 | 21% above |
| 100 week MA | $9.98 | 0.2% below |
| 200 week MA | $12.3 | 19% below |
VYX has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
VYX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.5 | $22.4 | +4.4% |
| 2021 | $22.4 | $24.1 | +7.5% |
| 2022 | $24.1 | $14.2 | -41% |
| 2023 | $14.2 | $16.9 | +19% |
| 2024 | $16.9 | $13.9 | -18% |
| 2025 | $13.9 | $10.5 | -24% |
| 2026 YTD | $10.5 | $9.96 | -5.5% |
VYX has the edge over ASTS on returns for 2026, with the stronger performance.